NRX Pharmaceuticals (NRXP) closed at $2.45 on November 17, 2026, up 14.0% from the previous close, on volume of 1,350,010 shares (30-day average 1,364,599).
Data as of November 17, 2026.
17-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 17, 2026. See the largest for 5, 30, 60 and 90 days
NRx Pharmaceuticals GAAP EPS of -$0.05 beats by $0.16, revenue of $1.16M misses by $0.13M
Seeking Alpha News (Tue, 17-Nov 7:24 AM ET)
Globe Newswire (Tue, 17-Nov 7:18 AM ET)
Here are the major earnings before the open Tuesday
Seeking Alpha News (Mon, 16-Nov 6:00 PM ET)
NRx Pharmaceuticals Q3 2026 Earnings Preview
Seeking Alpha News (Mon, 16-Nov 9:33 AM ET)
Globe Newswire (Thu, 12-Nov 4:01 PM ET)
NRx Pharmaceuticals Begins Selling U.S.-Made, Preservative-Free Ketamine Amid Long-Running Shortage
Globe Newswire (Wed, 11-Nov 7:00 AM ET)
Globe Newswire (Fri, 30-Oct 7:00 AM ET)
Globe Newswire (Thu, 29-Oct 4:00 PM ET)
Globe Newswire (Mon, 19-Oct 8:30 AM ET)
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
Globe Newswire (Thu, 15-Oct 8:27 AM ET)
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
NRX Pharmaceuticals trades on the NASDAQ stock market under the symbol NRXP.
As of November 17, 2026, NRXP stock price climbed to $2.45 with 1,350,010 million shares trading.
NRXP has a beta of 1.44, meaning it tends to be more sensitive to market movements. NRXP has a correlation of 0.07 to the broad based SPY ETF.
NRXP has a market cap of $108.60 million. This is considered a Micro Cap stock.
Last quarter NRX Pharmaceuticals reported $1 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-139,264 and exceeded earnings estimates by $.13.
In the last 3 years, NRXP traded as high as $7.33 and as low as $1.10.
The top ETF exchange traded funds that NRXP belongs to (by Net Assets): VTI, PSIL, VXF, IWC.
NRXP has outperformed the market in the last year with a price return of +16.1% while the SPY ETF gained +11.2%. However, in the short term, NRXP had mixed performance relative to the market. It has underperformed in the last 3 months, returning -28.6% vs -5.0% return in SPY. But in the last 2 weeks, NRXP shares have fared better than the market returning +9.4% compared to SPY -2.9%.
NRXP support price is $2.03 and resistance is $2.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NRXP shares will trade within this expected range on the day.